With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
The combination will support clients in getting their end-to-end discovery and development programs delivered.
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Approval marks fifth indication for KEYTRUDA-based regimens in NSCLC and 34th indication for KEYTRUDA in the US
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas
She joins Enveda from Gilead Sciences
Subscribe To Our Newsletter & Stay Updated
